Suppression of lymphocyte mitogenesis by tamoxifen: Studies on protein kinase C, calmodulin and calcium

被引:11
作者
Baral, E
Nagy, E
Kwok, S
McNicol, A
Gerrard, J
Berczi, I
机构
[1] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada
[2] Univ Manitoba, Fac Med, Dept Pediat, Winnipeg, MB R3E 0W3, Canada
[3] Univ Manitoba, Fac Med, Dept Pharmacol & Oral Biol, Winnipeg, MB R3E 0W3, Canada
[4] Univ Manitoba, Fac Med, Dept Internal Med, Winnipeg, MB R3E 0W3, Canada
[5] Univ Manitoba, Fac Med, Manitoba Canc Treatment & Res Fdn, Winnipeg, MB R3E 0W3, Canada
关键词
lymphocyte proliferation; tamoxifen; Ca2+;
D O I
10.1159/000026422
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of tamoxifen (TX; 1.0 mu M) on the mitogenic response of rat lymphocytes was compared with the effect of drugs that are known to act on protein kinase C (PKC), calmodulin (CM), and calcium (Ca2+). The calcium ionophore A23187 (0.2 mu M) was mitogenic on its own which was not influenced by TX, The agents modulating PKC or CM (phorbol-myristate-13-acetate; R24571, chlorpromazine) influenced mitogenesis differently than did TX, General inhibition of lymphocyte proliferation was seen with the Ca2+ antagonist agents (EGTA, TMB-8) as with TX. The antiproliferative effect of TX was partially reversed by the increase of Ca2+ in the culture medium when T cell mitogens were used, but not in the case of lipid A, a B lymphocyte mitogen. However, the concanavalin A-induced Ca2+ influx was further elevated by TX which differed from the effect of the Ca2+ channel-blocking agent verapamil. The results suggest that TX resets the threshold stimulus necessary for mitogenesis and is completely reversible. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:68 / 76
页数:9
相关论文
共 43 条
[1]  
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[2]  
BARAL E, 1987, J CLIN LAB IMMUNOL, V22, P97
[3]   TARGET-CELLS ARE SENSITIZED FOR CYTOTOXIC T-LYMPHOCYTE-MEDIATED DESTRUCTION BY ESTRADIOL AND TAMOXIFEN [J].
BARAL, E ;
NAGY, E ;
BERCZI, I .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (01) :64-68
[4]   THE INFLUENCE OF ESTRADIOL AND TAMOXIFEN ON THE MIXED LYMPHOCYTE-REACTION IN RATS [J].
BARAL, E ;
KWOK, S ;
BERCZI, I .
IMMUNOPHARMACOLOGY, 1991, 21 (03) :191-197
[5]   SUPPRESSION OF LYMPHOCYTE MITOGENESIS BY TAMOXIFEN [J].
BARAL, E ;
KWOK, S ;
BERCZI, I .
IMMUNOPHARMACOLOGY, 1989, 18 (01) :57-62
[6]  
BARAL E, 1986, J CLIN LAB IMMUNOL, V21, P137
[7]  
BARAL E, 1985, J CLIN LAB IMMUNOL, V17, P33
[8]  
BARAL E, 1995, CANCER-AM CANCER SOC, V75, P591, DOI 10.1002/1097-0142(19950115)75:2<591::AID-CNCR2820750224>3.0.CO
[9]  
2-U
[10]  
BARAL E, 1987, FUNDAMENTAL PROBLEMS, P235